FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/21/2026
Back to search
Official data from USPTO
REMPLIR - MODELING EPINEURIAL STRUCTURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REMPLIR - MODELING EPINEURIAL STRUCTURE
ST13
US500000079414297Class
5, 10
Filing
79414297
Registration
8217291
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/21/2026
Trademark type
Word
Nice classes
5, 10
Filing date
12/16/2024
Registration date
04/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Orthocell Limited
Representatives
Matthew J. Stark PRICE HENEVELD LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Collagen for medical purposes; surgical implants grown from stem cells being living tissue; therapeutic drugs and agents for use in tissue repair and regeneration; pharmaceutical and medical preparations for use in regeneration of damaged bone and soft tissueincluding nerve tissue; surgical and medical dressings; biological preparations for medical purposesfor use in tissue regeneration for tissue repair; biological preparations for medical usefor use in tissue regeneration for tissue repair; dental implant materials being implantable scaffolds comprising biological materials including living cells and collagen; collagen bioinks in the nature of biological tissues intended for subsequent implantation for clinical purposes; biological implants comprised of human or animal connective tissues intended for subsequent implantation; biological implantsliving cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; surgical implants comprised of living tissues; surgical mesh comprised primarily of living tissue; biotechnological preparations for medical purposesliving cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; biodegradable implants for use in guided tissue regenerationliving cells and implantable scaffolds comprising biological materials for use in human tissue regeneration and repair; collagen bioinks in the nature of biological tissue cells intended for subsequent implantation for clinical purposes; engineered human biological tissues being living cells and implantable scaffolds comprising biological materials for use in regenerative medicine; engineered animal biological tissues being living cells and implantable scaffolds comprising biological materials for use in regenerative medicine; biomaterials in the nature of biological tissue cells being living cells for medical purposes; biological tissue being living cells for implantation for use in tissue regeneration for tissue repair; engineered biological tissues being living cells for medical purposes
Class 10
Orthopaedic apparatusapparatus made from artificial biomaterials for use in the regeneration of bone and soft tissueincluding nerve tissue; orthopaedic articlesapparatus made from artificial biomaterials for use in the regeneration of bone and soft tissueincluding nerve tissue; medical implants made from artificial materials; surgical implants comprised of artificial materials; surgical implants comprised of artificial materials for use in guided tissue regeneration; orthopaedic implantsimplants made from artificial biomaterials for use in the regeneration of bone and soft tissueincluding nerve tissue; artificial orthopaedic implantsimplants made from artificial biomaterials for use in the regeneration of bone and soft tissueincluding nerve tissue; implants being prostheses of artificial biomaterialsbone prostheses and soft tissue prostheses for replacing bone and soft tissue for use in the body; implants being prostheses of artificial biomaterialsdental prostheses for dental surgery; implants being prostheses of artificial biomaterialsbone prostheses for bone surgery; implants being prostheses of artificial biomaterialsdental and bone prostheses for use in facial surgery; implants being prostheses of artificial biomaterialsbone prostheses for use in bone grafting; otological prostheses being prostheses consisting of artificial biomaterials; dental implants; artificial surgical implants comprising artificial biomaterials; therapeutic articles for implantationsurgical implantsmade of artificial materials
Publications
History of USPTO decisions and trademark events.
22 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/25/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/08/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/08/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/21/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2026
PUBO
PUBLISHED FOR OPPOSITION
03/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/25/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/29/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/29/2026
RFNT
REFUSAL PROCESSED BY IB
08/15/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/30/2025
RFRR
REFUSAL PROCESSED BY MPU
07/30/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/10/2025
CNRT
NON-FINAL ACTION WRITTEN
06/09/2025
DOCK
ASSIGNED TO EXAMINER
06/02/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/10/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/09/2025
Continuous trademark protection
Get notified about every new filing that threatens REMPLIR - MODELING EPINEURIAL STRUCTURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.